SciELO - Scientific Electronic Library Online

 
vol.68 issue1Autoimmune diseases in patients with common variable immunodeficiencyContact dermatitis caused by diagnostic devices and surgical orthopedic treatment author indexsubject indexsearch form
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

Related links

  • Have no similar articlesSimilars in SciELO

Share


Revista alergia México

On-line version ISSN 2448-9190

Abstract

RENDON-MACIAS, Mario Enrique; GARCIA, Heladia  and  VILLASIS-KEEVER, Miguel Ángel. Risk, association, and impact measures in clinical research studies. How to interpret them for their application in medical care. Rev. alerg. Méx. [online]. 2021, vol.68, n.1, pp.65-75.  Epub Aug 30, 2021. ISSN 2448-9190.  https://doi.org/10.29262/ram.v68i1.886.

The practice of evidence-based medicine includes the critical analysis of clinical research studies, and, within it, the interpretation of the results reported. In addition, to statistical data, there are estimators that can help clinicians transfer research findings to routine clinical practice. These estimators are measures of risk, association, and impact. Risk measures report current uncertainty or probability (prevalence of a disease, sensitivity, specificity) or for future events (cumulative incidence, incidence density). Measures of association are related to the identification of the risk in order to determine whether certain factors increase or decrease the probability of development of a disease (relative risk, odds ratio, hazard ratio). While measures of impact allow, among other things, to estimate the effect of a treatment (relative risk reduction, absolute risk reduction, number needed to treat). In this review, each of these estimators is described, defined, and presented with examples.

Keywords : Risk measures; Measures of association; Measures of impact; Evidence-based medicine.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )